Outset Medical, Inc. (OM)
NASDAQ: OM · Real-Time Price · USD
17.61
-1.83 (-9.41%)
At close: Jul 24, 2025, 4:00 PM
17.94
+0.33 (1.87%)
After-hours: Jul 24, 2025, 5:31 PM EDT

Company Description

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States.

The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.

It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform.

The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015.

Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Outset Medical, Inc.
Outset Medical logo
CountryUnited States
Founded2003
IPO DateSep 15, 2020
IndustryMedical Devices
SectorHealthcare
Employees354
CEOLeslie Trigg

Contact Details

Address:
3052 Orchard Drive
San Jose, California 95134
United States
Phone669 231 8200
Websiteoutsetmedical.com

Stock Details

Ticker SymbolOM
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
IPO Price$27.00
CIK Code0001484612
CUSIP Number690145107
ISIN NumberUS6901452069
Employer ID20-0514392
SIC Code3845

Key Executives

NamePosition
Leslie L. TriggPresident, Chief Executive Officer and Chairman
John L. Brottem J.D.General Counsel and Secretary
Renee M. GaetaChief Financial Officer, Principal Financial Officer and Principal Accounting Officer
Marc NashSenior Vice President of Operations and Research & Development
James S. MazzolaHead of Investor Relations
Laura RomikeSenior Vice President of Sales
Amelia MerrillVice President of People Operations and Culture
Dr. Michael Aragon M.D.Chief Medical Officer
Jennifer SippleSenior Vice President of Customer Experience
Dinamarie StefaniSenior Vice President of Regulatory Affairs and Quality Assurance

Latest SEC Filings

DateTypeTitle
Jul 17, 2025SCHEDULE 13GFiling
Jun 5, 2025S-8Securities to be offered to employees in employee benefit plans
Jun 3, 20258-KCurrent Report
May 29, 2025SDForm - SD
May 15, 2025144Filing
May 15, 2025144Filing
May 15, 2025144Filing
May 15, 2025144Filing
May 15, 2025SCHEDULE 13G/AFiling
May 15, 2025SCHEDULE 13GFiling